Innovative Drug Development

Interviews
Bülent Denkdemir, CEO of Trustlife Ventures: At Trustlife, we conduct drug development studies using very advanced algorithms based on human data and artificial intelligence.
Congresses
Ten of our researchers attended the International Congress of Medicinal Chemistry
Interviews
Trustlife Labs Pharmaceutical R&D Centre - Interviews
Interviews
Trustlife, an SPK-approved venture capital investment fund, operates with a multidisciplinary approach aimed at bringing scientific research and innovative ideas together with investors.
Congresses
Bioexpo 2023 Panel: The Role of Artificial Intelligence in Drug Development
Presantations
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridging the Gap from Lab to Clinic
Presantations
Systems Biology & Artificial Intelligence Based Drug Development
Presantations
Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis
Scientific Documents
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Scientific Documents
Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
Project Calls
Innovative Drug (Small Molecule) Development Project Call Results Announced
Project Calls
Trustlife Panelist Selection Has Been Made
Scientific Documents
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
Project Calls
Trustlife Project Call Documentation Released
Project Calls
Project Call Theme Announced